Jinyu Bio-technology Co., Ltd. (SHA:600201)
China
· Delayed Price · Currency is CNY 14.71
-0.24 (-1.61%)
Mar 9, 2026, 11:29 AM CST
Jinyu Bio-technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,297 | 1,225 | 1,508 | 1,485 | 1,754 | 1,567 | Upgrade
|
| Other Revenue | 30.13 | 30.13 | 89.92 | 43.97 | 22.64 | 14.59 | Upgrade
|
| Revenue | 1,327 | 1,255 | 1,598 | 1,529 | 1,776 | 1,582 | Upgrade
|
| Revenue Growth (YoY) | -1.70% | -21.45% | 4.55% | -13.94% | 12.29% | 40.39% | Upgrade
|
| Cost of Revenue | 652.67 | 597.17 | 668.1 | 697.3 | 688.81 | 621.66 | Upgrade
|
| Gross Profit | 674.39 | 658.29 | 930.13 | 831.37 | 1,088 | 960.25 | Upgrade
|
| Selling, General & Admin | 500.35 | 432.34 | 491.55 | 421.77 | 501.9 | 400.14 | Upgrade
|
| Research & Development | 144.81 | 136.82 | 143.47 | 133.78 | 165.94 | 130.83 | Upgrade
|
| Other Operating Expenses | 42.83 | 21.83 | 23.14 | 22.26 | 24.5 | 23.24 | Upgrade
|
| Operating Expenses | 731.32 | 621.1 | 681.43 | 579.36 | 693.32 | 553.26 | Upgrade
|
| Operating Income | -56.93 | 37.19 | 248.7 | 252.01 | 394.19 | 406.99 | Upgrade
|
| Interest Expense | -0.75 | -5.5 | -0.05 | -4.81 | -0.04 | -0.97 | Upgrade
|
| Interest & Investment Income | 67.75 | 55.36 | 56.52 | 50.91 | 47.57 | 45.06 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.05 | 0.05 | -0.02 | 0.08 | -0.05 | -0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.81 | -0.58 | 0.15 | 0.21 | -0.76 | -1.89 | Upgrade
|
| EBT Excluding Unusual Items | 9.3 | 86.52 | 305.28 | 298.39 | 440.91 | 448.97 | Upgrade
|
| Impairment of Goodwill | -3.21 | -3.21 | -18.08 | -65.02 | -39.75 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.31 | -9.49 | -7.78 | -9.81 | -3.22 | 8.48 | Upgrade
|
| Gain (Loss) on Sale of Assets | 10.84 | 2.58 | -0.04 | -0.04 | -2.31 | 0.04 | Upgrade
|
| Asset Writedown | 0.95 | -11.11 | -5.34 | -1.54 | -1.99 | -0.4 | Upgrade
|
| Other Unusual Items | 93.92 | 59.63 | 41.78 | 23.61 | 19.65 | 19.12 | Upgrade
|
| Pretax Income | 110.49 | 124.91 | 315.83 | 245.58 | 413.27 | 476.21 | Upgrade
|
| Income Tax Expense | 17.39 | 20.76 | 38.73 | 45.46 | 24.27 | 53.82 | Upgrade
|
| Earnings From Continuing Operations | 93.1 | 104.15 | 277.1 | 200.12 | 389.01 | 422.39 | Upgrade
|
| Minority Interest in Earnings | 7.66 | 4.83 | 6.53 | 10.54 | -6.72 | -16.19 | Upgrade
|
| Net Income | 100.76 | 108.99 | 283.63 | 210.66 | 382.29 | 406.2 | Upgrade
|
| Net Income to Common | 100.76 | 108.99 | 283.63 | 210.66 | 382.29 | 406.2 | Upgrade
|
| Net Income Growth | -38.88% | -61.58% | 34.64% | -44.90% | -5.89% | 83.76% | Upgrade
|
| Shares Outstanding (Basic) | 1,049 | 1,090 | 1,091 | 1,109 | 1,124 | 1,128 | Upgrade
|
| Shares Outstanding (Diluted) | 1,049 | 1,090 | 1,091 | 1,109 | 1,124 | 1,128 | Upgrade
|
| Shares Change (YoY) | -5.26% | -0.10% | -1.61% | -1.39% | -0.35% | 2.09% | Upgrade
|
| EPS (Basic) | 0.10 | 0.10 | 0.26 | 0.19 | 0.34 | 0.36 | Upgrade
|
| EPS (Diluted) | 0.10 | 0.10 | 0.26 | 0.19 | 0.34 | 0.36 | Upgrade
|
| EPS Growth | -35.49% | -61.54% | 36.84% | -44.12% | -5.56% | 80.00% | Upgrade
|
| Free Cash Flow | 186.87 | 199.89 | 141.67 | 154.54 | 160.4 | 471.3 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.18 | 0.13 | 0.14 | 0.14 | 0.42 | Upgrade
|
| Dividend Per Share | 0.030 | 0.030 | 0.080 | 0.060 | 0.110 | 0.120 | Upgrade
|
| Dividend Growth | -62.50% | -62.50% | 33.33% | -45.45% | -8.33% | 100.00% | Upgrade
|
| Gross Margin | 50.82% | 52.43% | 58.20% | 54.38% | 61.22% | 60.70% | Upgrade
|
| Operating Margin | -4.29% | 2.96% | 15.56% | 16.49% | 22.19% | 25.73% | Upgrade
|
| Profit Margin | 7.59% | 8.68% | 17.75% | 13.78% | 21.52% | 25.68% | Upgrade
|
| Free Cash Flow Margin | 14.08% | 15.92% | 8.86% | 10.11% | 9.03% | 29.79% | Upgrade
|
| EBITDA | 168.2 | 246.61 | 437.17 | 450.92 | 585.17 | 580.63 | Upgrade
|
| EBITDA Margin | 12.68% | 19.64% | 27.35% | 29.50% | 32.94% | 36.70% | Upgrade
|
| D&A For EBITDA | 225.12 | 209.42 | 188.47 | 198.91 | 190.98 | 173.64 | Upgrade
|
| EBIT | -56.93 | 37.19 | 248.7 | 252.01 | 394.19 | 406.99 | Upgrade
|
| EBIT Margin | -4.29% | 2.96% | 15.56% | 16.48% | 22.19% | 25.73% | Upgrade
|
| Effective Tax Rate | 15.74% | 16.62% | 12.26% | 18.51% | 5.87% | 11.30% | Upgrade
|
| Revenue as Reported | 1,327 | 1,255 | 1,598 | 1,529 | 1,776 | 1,582 | Upgrade
|
| Advertising Expenses | - | 162.42 | 179.06 | 166.38 | 241.94 | 172.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.